Viewing Study NCT02313818


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-03-04 @ 10:12 PM
Study NCT ID: NCT02313818
Status: COMPLETED
Last Update Posted: 2019-01-16
First Post: 2014-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Variable-length Cognitive Processing Therapy for Combat-Related PTSD
Sponsor: Duke University
Organization:

Study Overview

Official Title: Variable-length Cognitive Processing Therapy for Combat-Related PTSD
Status: COMPLETED
Status Verified Date: 2018-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary goal of this study is to improve the overall efficacy of cognitive processing therapy-cognitive-only version (CPT-C) in a sample of 130 active-duty service members through a variable length treatment.
Detailed Description: The primary goal of this study is to improve the overall efficacy of cognitive processing therapy-cognitive-only version (CPT-C) in a sample of 130 active-duty service members through a variable length treatment. The study seeks to determine if some service members would benefit from a longer or shorter dose of treatment (4-24 sessions), and to identify which individuals are likely to require more, less, or the standard number of treatment sessions to reach good end-state functioning. Predictors of length of therapy and treatment outcome will be examined. Specifically, we will evaluate factors related to internalizing/externalizing traits, cognitive flexibility, inability to inhibit dysfunctional cognitions, and readiness to change as they are related to the number of treatment sessions required to treat patients to the point of good end-state functioning. Additional outcomes including alcohol use, psychosocial functioning, physical health, and sleep also will be evaluated.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
W81XWH-13-2-0012 OTHER VA Boston Healthcare System View